Peptide-Based Strategy for siRNA Delivery into Mammalian Cells
| Autor: | Frédéric Heitz, Federica Simeoni, Gilles Divita, May C. Morris |
|---|---|
| Přispěvatelé: | Centre de recherches de biochimie macromoléculaire (CRBM), Centre National de la Recherche Scientifique (CNRS)-IFR122-Université Montpellier 2 - Sciences et Techniques (UM2)-Université Montpellier 1 (UM1) |
| Rok vydání: | 2005 |
| Předmět: |
chemistry.chemical_classification
0303 health sciences Complete Growth Medium business.industry Chemistry Endosomal Pathway Nuclear Localization Sequence siRNA Delivery Invitrogen Life Technology RNA Peptide Computational biology 03 medical and health sciences 0302 clinical medicine Text mining RNA interference 030220 oncology & carcinogenesis [SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biology business 030304 developmental biology |
| Zdroj: | RNA Silencing RNA Silencing, 309, Humana Press, pp.251-260, 2005, ⟨10.1385/1-59259-935-4:251⟩ |
| Popis: | International audience; The potential to control and alter gene expression constitutes an essential strategy in both fundamental and pharmaceutical research. The recent discovery of the RNA interference pathway in a wide variety of eukaryotic organisms has provided a novel means of characterizing gene function in mammalian cells and new perspectives in both molecular biology and future therapeutic developments (1, 2, 3). Short, interfering RNAs (siRNAs) constitute a powerful tool to silence gene expression posttranscriptionally (1, 2, 3). However, the major limitation of siRNA application, as for most antisense or nucleic acid-based strategies, remains their poor cellular uptake associated with low permeability of the cell membrane to nucleic acids (4,5). Several viral (6, 7, 8, 9) and nonviral (6,10) strategies have been proposed to improve the delivery of either siRNAs expressing vectors or synthetic siRNAs, both in cultured cells and in vivo (6). So far, although siRNA transfection can be achieved with classical laboratory-cultured cell lines using lipid-based formulations, siRNA delivery remains a major challenge for many cell lines and there is still no reasonably efficient method for in vivo application (6). The most efficient method for in vivo applications is the nonviral “hydrodynamic” tail-vein injection of mice with high doses of siRNA (11, 12, 13). Cell-penetrating peptides are powerful carriers for cellular uptake of a variety of macromolecules, including proteins, peptides, and oligonucleotides (14, 15, 16, 17). Several peptide-based strategies have been developed to improve the delivery of oligonucleotides both in vitro and in vivo using either covalent or complex approaches (18, 19, 20). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|